Squamous cell carcinomas of the head and neck

被引：219

作者：

Sanderson, RJ ^{[1
]}

Ironside, JAD ^{[1
]}

机构：

[1] Western Gen Hosp, Edinburgh Canc Ctr, Edinburgh EH4 2XU, Midlothian, Scotland

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2002年 / 325卷 / 7368期

关键词：

D O I：

10.1136/bmj.325.7368.822

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：822 / 827

页数：6

共 32 条

[1] A prospective study of quality of life in head and neck cancer patients.: Part II:: Longitudinal data [J].

Bjordal, K ;

Ahlner-Elmqvist, M ;

Hammerlid, E ;

Boysen, M ;

Evensen, JF ;

Biörklund, A ;

Jannert, M ;

Westin, T ;

Kaasa, S .

LARYNGOSCOPE, 2001, 111 (08) :1440-1452

[2]

*BRIT ASS OT HEAD, 2000, EFF HEAD NECK CANC M

[3] Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis [J].

Browman, GP ;

Hodson, DI ;

Mackenzie, RJ ;

Bestic, N ;

Zuraw, L .

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2001, 23 (07) :579-589

[4]

Capizzi RL, 2000, INT J HEMATOL, V72, P425

[5] Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: A phase II study of the Southern Italy Cooperative Oncology Group (SICOG) [J].

Caponigro, F ;

Massa, E ;

Manzione, L ;

Rosati, G ;

Biglietto, M ;

De Lucia, L ;

Sguotti, C ;

Sganga, P ;

Avallone, A ;

Comella, P ;

Mantovani, G ;

Comella, G .

ANNALS OF ONCOLOGY, 2001, 12 (02) :199-202

[6]

*DEP HLTH, 2002, REF GUID SUSP CANC

[7] A prospective study of quality of life in head and neck cancer patients.: Part I:: At diagnosis [J].

Hammerlid, E ;

Bjordal, K ;

Ahlner-Elmqvist, M ;

Boysen, M ;

Evensen, JF ;

Biörklund, A ;

Jannert, M ;

Kaasa, S ;

Sullivan, M ;

Westin, T .

LARYNGOSCOPE, 2001, 111 (04) :669-680

[8] Concomitant chemoradiation for head and neck cancer: Saving lives or grays? [J].

Henk, JM .

CLINICAL ONCOLOGY, 2001, 13 (05) :333-335

[9] Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: A prospective randomized trial [J].

Jeremic, B ;

Shibamoto, Y ;

Stanisavljevic, B ;

Milojevic, L ;

Milicic, B ;

Nikolic, N .

RADIOTHERAPY AND ONCOLOGY, 1997, 43 (01) :29-37

[10] A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer [J].

Khuri, FR ;

Nemunaitis, J ;

Ganly, I ;

Arseneau, J ;

Tannock, IF ;

Romel, L ;

Gore, M ;

Ironside, J ;

MacDougall, RH ;

Heise, C ;

Randlev, B ;

Gillenwater, AM ;

Bruso, P ;

Kaye, SB ;

Hong, WK ;

Kirn, DH .

NATURE MEDICINE, 2000, 6 (08) :879-885

← 1 2 3 4 →